Recombinant tissue-type plasminogen activator current concepts guidelines clinical use acute myocardial infarction Part II high prevalence coronary heart disease incidence MI Western society investigation development pharmacologic agents Recombinant t-PA vital role treatment MI coronary arterial patency infarct size ventricular function patient survival safe patients indications clinical use Future investigations patient selection treatment patients benefit dosing regimens adjuvant therapies coronary reperfusion reocclusion hemorrhagic complications 